Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)

Summary

  • HIV infection alters the natural history of HCV disease and is associated with increased chronicity, accelerated progression to end-stage liver disease, and increased risk of liver-related death[Weber 2006; Soriano 2013]
    • Urgency for HCV treatment is greater in HCV/HIV-coinfected persons than in HCV monoinfection
  • Successful treatment of HCV may improve the tolerability of ART by reducing risk of hepatotoxicity[Labarga 2007; Soriano 1996]

Action required

Keywords: Hepatitis C, Hepatitis C-Epidemiology, Hepatitis C-Pathogenesis and Natural History, Hepatitis C-Special Populations

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.